Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (16.685)

1

Machine Learning-Based Quantification of Patient Factors Impacting Remission in Patients With Ulcerative Colitis : Insights from Etrolizumab Phase III Clinical Trials

enthalten in: Clinical pharmacology and therapeutics | 2024

von Harun, R. | Lu, J. | Kassir, N. | +1

2

Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer

enthalten in: Cancer | 2024

von Hinchcliff, E. | Knisely, A. | Adjei, N. | +18

3

CD46 and CD59 inhibitors enhance complement-dependent cytotoxicity of anti-CD38 monoclonal antibodies daratumumab and isatuximab in multiple myeloma and other B-cell malignancy cells

enthalten in: Cancer biology & therapy | 2024

von Wang, H. | Koob, T. | Fromm, J. | +3

4

An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancer

enthalten in: Molecular cancer | 2024

von Levy, A. | Morel, D. | Texier, M. | +21

5

Clinical dose rationale of tislelizumab in patients with solid or hematological advanced tumors

enthalten in: Clinical and translational science | 2024

von Yu, T. | Liu, X. | Wu, C. | +9

6

Prognostic value of the Scottish Inflammatory prognostic Score in patients with NSCLC expressing PD-L1 ≥ 50 % progressing on first-line pembrolizumab

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2024

von Stares, M. | Doyle, E. | Chapple, S. | +6

7

Comparative Efficacy and Safety of Monoclonal Antibodies for Cognitive Decline in Patients with Alzheimer's Disease : A Systematic Review and Network Meta-Analysis

enthalten in: CNS drugs | 2024

von Qiao, Y. | Gu, J. | Yu, M. | +2

8

Comparison of three methods for the detection of antibodies against muscle-specific kinase

enthalten in: Journal of immunological methods | 2024

von Luong, K. | Lozier, B. | Novis, C. | +3

9

Immunogenicity of avelumab in patients with metastatic Merkel cell carcinoma or advanced urothelial carcinoma

enthalten in: Clinical and translational science | 2024

von Hu, P. | Dai, H. | Bourdage, J. | +10

10

Niraparib plus Dostarlimab in Pleural Mesothelioma or Non-Small Cell Lung Cancer Harboring HRR Mutations : Interim Results of the UNITO-001 Phase II Prospective Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Passiglia, F. | Righi, L. | Bironzo, P. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[1669]